NuvaRing Blood Clot Studies Spark Hundreds of Lawsuits

By Sarah Mirando | August 16, 2012

Category: Pharmaceuticals

{loadposition nuvaring_lawsuit}

By Matt O’Donnell

Millions of women worldwide have used the vaginal ring contraceptive NuvaRing as a convenient method of birth control, thinking NuvaRing was safer than traditional birth control pills. However, several recent studies have linked NuvaRing to dangerous blood clot side effects such as pulmonary embolism, deep vein thrombosis, heart attack, stroke and even death. As a result, nearly 1,000 NuvaRing lawsuits have been filed against the drug makers for concealing these risks from women.

NuvaRing was approved in the United States in October 2001 and first marketed in July 2002 as a birth control device that’s inserted into the vagina and delivers a low dose of hormones to prevent pregnancy. NuvaRing was marketed as a safer alternative to the pill, but several recent studies have proved otherwise. These studies have been prompted hundreds of NuvaRing lawsuits as women discover their blood clot injuries were caused by NuvaRing.

NuvaRing Blood Clot Studies

A recent study published May 2012 in the British Medical Journal found that women who use NuvaRing are 6.5 times more likely to suffer from venous thrombosis, a classification of blood clot injuries that includes pulmonary embolism and deep vein thrombosis, than women who do not use hormonal birth control. The study also found that NuvaRing users are 90% more likely to have a dangerous blood clot than women who use the pill.

An October 2011 NuvaRing blood clot study by the FDA found that using NuvaRing increased the risk of deep vein thrombosis (DVT) by about 55%.

In June 2012, Danish researchers published a NuvaRing blood clot study in The New England Journal of Medicine that showed NuvaRing increases the risk of dangerous blood clots and doubles the risk of stroke and heart attack.

Nearly 1,000 NuvaRing Lawsuits Filed

As information from these studies reaches more women, they’ve turned to litigation to pursue compensation for their NuvaRing blood clot injuries — injuries that could have been avoided if the drug makers, Merck and Organon, had properly warned the public of the life-threatening side effects of NuvaRing. The majority of these lawsuits accuse the drug makers of concealing these side effects in order to get NuvaRing on the market and increase their bottom line — flagrantly disregarding human life.

Plaintiffs in NuvaRing lawsuits allege they suffered multiple complications and side effects from NuvaRing, including:

* Pulmonary Embolism (PE)

* Deep Vein Thrombosis (DVT)

* Heart Attack

* Stoke

* Wrongful Death

They are seeking compensation from Merck and Organon for defective product design, failure to warn, negligence and other claims. If you suffered one of these NuvaRing side effects, you too may be able to seek compensation for your medical expenses, pain and suffering, loss of income, and more. Family members of NuvaRing users who died from blood clot complications can also pursue compensation through a wrongful death lawsuit.

Visit the NuvaRing Birth Control Class Action Lawsuit Settlement & Investigation to receive more information about how to file a NuvaRing injury lawsuit, NuvaRing class action lawsuit or how to join the NuvaRing MDL or NuvaRing Mass Tort. NuvaRing injury lawyers are waiting to hear from you, and will provide a free consultation about your legal rights.

Updated August 16th, 2012

{loadposition content_postads}

All medical device, dangerous drug and medical class action and lawsuit news updates are listed in the Drug and Medical Device section of Top Class Actions.

LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement

Various Trademarks held by their respective owners.